source name	characteristics[organism]	characteristics[organism part]	characteristics[strain/breed]	characteristics[developmental stage]	characteristics[disease]	characteristics[sex]	characteristics[ancestry category]	characteristics[age]	characteristics[cultured cell]	characteristics[cell line]	characteristics[cell type]	characteristics[individual]	characteristics[biological replicate]	Material Type	assay name	Technology Type	comment[data file]	comment[label]	comment[fractionation method]	comment[technical replicate]	comment[fraction identifier]	comment[ms2 mass analyzer]	comment[instrument]	comment[separation]	comment[file uri]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	factor value[organism part]
PXD011839-Sample-62	homo sapiens	blood plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	1	not available	run 226	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	http://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD011839/20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_62_F1.raw	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	20 ppm	20 ppm		blood plasma
PXD011839-Sample-62	homo sapiens	blood plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	1	not available	run 303	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	2	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	http://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD011839/20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_62_F1.raw	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	20 ppm	20 ppm		blood plasma
PXD011839-Sample-62	homo sapiens	blood plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	1	not available	run 380	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	3	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	http://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD011839/20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_62_F1.raw	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	20 ppm	20 ppm		blood plasma
